Although economic gloom is everywhere and President Trump is triggering a rumpus with his 'America initially' approach, the UK stock exchange remains unfazed.

Despite a couple of wobbles recently - and more to come as Trump rattles international cages - both the FTSE100 and wider FTSE All-Share indices have actually been resistant.

Both are more than 13 per cent higher than this time last year - and close to tape highs.

Against this background of economic uncertainty, Trump rhetoric and near-market highs, it's hard to think that any outstanding UK investment opportunities for patient investors exist - so called 'healing' scenarios, where there is potential for the share cost of particular business to rise like a phoenix from the ashes.

But a band of fund supervisors is specialising in this contrarian type of investing: purchasing undervalued business in the expectation that over time the marketplace will show their real worth.

This undervaluation might result from poor management leading to service errors; a hostile financial and monetary background; or larger problems in the industry in which they operate.

Rising like a phoenix: Buying underestimated companies in the hope that they'll ultimately skyrocket needs nerves of steel and limitless patience

Yet, the fund supervisors who buy these shares believe the 'issues' are solvable, although it may use up to five years (sometimes less) for the results to be reflected in far greater share costs. Sometimes, to their dismay, the issues prove unsolvable.

Max King spent thirty years in the City as a financial investment supervisor with the similarity J O Hambro Capital Management and Investec. He states investing for healing is high risk, requires perseverance, a neglect for agreement investment thinking - and nerves of steel.

He likewise thinks it has ended up being crowded out by both the growth in inexpensive passive funds which track particular stock exchange indices - and the appeal of development investing, constructed around the success of the big tech stocks in the US.

Yet he firmly insists that healing investing is far from dead.

In 2015, King states various UK healing stocks made investors sensational returns - consisting of banks NatWest and Barclays (still recuperating from the 2008 global financial crisis) and aerospace and defence huge Rolls-Royce Holdings (flourishing again after the impact of the 2020 pandemic lockdown). They generated particular returns for shareholders of 83, 74 and 90 percent.

Some shares, states King, have more to use investors as they advance from recovery to growth. 'Recovery investors frequently buy too early,' he states, 'then they get bored and offer too early.'

But more importantly, he believes that brand-new recovery opportunities always provide themselves, even in a rising stock exchange. For brave financiers who buy shares in these healing scenarios, outstanding returns can lie at the end of the rainbow.

With that in mind, Wealth asked four leading fund supervisors to recognize the most compelling UK recovery opportunities.

They are Ian Lance, manager of financial investment trust Temple Bar and Alex Wright who runs fund Fidelity Special Situations and trust Fidelity Special Values. These 2 managers embrace the recovery financial investment thesis 100 percent.

Completing the quartet are Laura Foll, who with James Henderson runs the investment portfolio of trust Law Debenture, and Imran Sattar of financial investment trust Edinburgh.

These 2 managers buy recovery stocks when the financial investment case is compelling, however only as part of wider portfolios.

Can you make a fortune wagering that shares in our greatest ... Why has the FTSE 100 hit record highs? INVESTING SHOW

How to select the finest (and most inexpensive) stocks and shares Isa and the ideal DIY investing account

' Recovery stocks remain in our DNA,' states Lance who runs the ₤ 800 million Temple Bar with Nick Purves. 'The logic is simple. A company makes a tactical error - for instance, a bad acquisition - and their share price gets cratered. We purchase the shares and after that wait for a catalyst - for instance, a modification in management or organization technique - which will transform the company's fortunes.

' Part of this process is speaking with the business. But as a financier, you need to be client.'

Recent success stories for Temple include Marks & Spencer which it has actually owned for the past five years and whose shares are up 44 percent over the previous year, 91 per cent over the past 5.

Fidelity's Wright states purchasing recovery shares is what he provides for a living. 'We purchase unloved business and then hold them while they ideally go through positive modification,' he explains.

' Typically, any recovery in the share rate takes in between 3 and five years to come through, although occasionally, as occurred with insurance provider Direct Line, the recovery can come quicker.'

In 2015, Direct Line's board accepted a takeover offer from rival Aviva, valuing its shares at ₤ 2.75. As a result, its shares increased more than 60 percent.

Foll states recovery stocks 'are often big drivers of portfolio efficiency'. The best UK ones, she states, are to be discovered among underperforming mid-cap stocks with a domestic business focus.

Sattar states Edinburgh's portfolio is 'diverse' and 'all weather' with an emphasis on high-quality companies - it's awash with FTSE100 stocks.

So, healing stocks are just a slivver of its possessions.

' For us to buy a healing stock, it needs to be first and foremost a great service.'

So, here are our financial investment professionals' top choices. As Lance and Wright have actually said, they may take a while to make decent returns - and nothing is ensured in investing, especially if Labour continues to make a pig's ear of promoting financial development.

But your perseverance might be well rewarded for welcoming 'recovery' as part of your long-term investment portfolio.

> Search for the stocks listed below, newest performance, yield and more in This is Money's share centre

WINNERS IN A POSSIBLE HOME BUILDING BOOM Marshalls is the nation's leading provider of building, landscaping, and roofing items - purchasing roofing professional Marley 3 years earlier.

Yet it has actually struggled to grow profits against the backdrop of 'tough markets' - last month it said its revenue had fallen ₤ 52million to ₤ 619 million in 2024.

The share cost has actually gone nowhere, falling 10 and 25 per cent over the past one and two years.

Yet, lower rates of interest - a 0.25 per cent cut was revealed by the Ban > k of England last Thursday - and the meeting of an annual housebuilding target of 300,000 set by Chancellor Rachel Reeves may help fire up Marshalls' share rate.

Law Debenture's Foll states any pick-up in housebuilding must lead to a demand surge for Marshalls' items, flowing through to higher earnings. 'Shareholders could take pleasure in attractive overall returns,' she says, 'although it may take a while for them to come through.' Edinburgh's Sattar also likes Marshalls although, unlike Foll who already holds the company's shares in Law Debenture's portfolio, it is just on his 'radar'.

He says: 'Its sales volumes are still listed below pre-pandemic levels. If the Chancellor does her bit to re-

spark housebuilding, then it should be a beneficiary as a provider of materials to new homes.'

Sattar also has an eye on contractors' merchant which he has owned in the past. 'It has fresh management on board [a new chairman and chief executive] and I have a meeting with them quickly,' he states.

' From an investment perspective, it's a picks and shovels approach to gaining from any growth in the real estate market which I prefer to purchasing shares in specific housebuilders.'

Like Marshalls, Travis Perkins' shares have actually gone no place, falling by 7, 33 and townshipmarket.co.za 50 percent over one, 2 and 3 years.

Another beneficiary of a possible housebuilding boom is brick maker Ibstock. 'The company has big repaired expenses as an outcome of heating up the big kilns needed to make bricks,' states Foll.

' Any uptick in housebuilding will increase brick production and sales, having an overstated benefit on its operating expense.'

Lower rates of interest, she adds, need to also be a positive for Ibstock. Although its shares are 14 percent up over the past year, they are up a meagre 0.3 percent over two years, and down 11 and 42 per cent over 3 and 5 years.

Fidelity's Wright has likewise been buying shares in two business which would gain from an improvement in the housing market - kitchen area supplier Howden Joinery Group and wiki.rrtn.org retailer DFS Furniture.

Both companies, he states, are gaining from having a hard time competitors. In Howden's case, competing Magnet has been closing showrooms, while DFS rival SCS was bought by Italy's Poltronesofa, which then closed lots of SCS stores for repair.

DFS, a Midas pick last month, has seen its share rate increase by 17 per cent over the past year, but is still down 41 percent over 3 years. Howden, a constituent of the FTSE 100, has made gains of 6 percent over both one and three years.

Six lessons from the pandemic stock market age, by investing master TOM STEVENSON

FUND MANAGER WORTH MORE THAN ITS PARTS Temple Bar's Lance doesn't mince his words when discussing FTSE250-listed fund manager Abdrn. 'People are right when they explain it as a rather struggling fund management company,' he states.

'Yet what they frequently don't realise is that it also owns an effective financial investment platform in Interactive Investor and an adviser business that, combined, forum.pinoo.com.tr justify its market capitalisation. In effect, the marketplace is putting little value on its fund management service. '

Include a pension fund surplus, a huge multi-million-pound stake in insurance company Phoenix - and Lance says shares in Abrdn have 'terrific recovery capacity'.

Temple Bar took a stake in the organization at the tail end of last year. Lance is enthused by the company's brand-new management team which is intent on cutting expenses.

Over the previous one and 3 years, the shares are down 3 and 34 percent, respectively.

OTHER RECOVERY POSSIBILITIES Fidelity's Wright says a healing stock tends to go through three unique stages.

First, a company embarks on favorable change (stage one, when the shares are dirt inexpensive). Then, the stock exchange recognises that modification remains in development (stage 2, reflected by an increasing share price), and lastly the cost totally reflects the modifications made (phase 3 - and time to think about offering).

Among those shares he holds in the phase one container (the most interesting from a financier perspective) is advertising giant WPP. Wright bought WPP in 2015 for Special Values and Special Situations.

Over one, two and 3 years, its shares are respectively up by 1 percent and down by 22 and oke.zone 33 per cent.

'WPP's shares are low-cost due to the fact that of the challenging advertising backdrop and issues over the possible disruptive effect of expert system (AI) on its revenues,' he states. 'But our analysis, based in part on speaking with WPP clients, suggests that AI will not disrupt its organization model.'

Other recovery stocks discussed by our professionals include engineering giant Spirax Group. Its shares are down 21 percent over the previous year, however Edinburgh's Sattar says it is a 'brilliant UK commercial business, worldwide in reach'.

He is also a fan of bug control huge Rentokil Initial which has actually experienced duplicated 'hiccups' over its costly 2022 acquisition of US business Terminix.

Sattar holds both stocks in the ₤ 1.1 billion trust.